Hospital-acquired pneumonia caused by multidrug-resistant Streptococcus pneumoniae serotype 15A
Infection · 2026
DOI: 10.1007/s15010-025-02652-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Infection, 2026. Verfasst von Hidemasa Akazawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Drug Resistance, Multiple, Bacterial, Pneumonia, Pneumococcal, Healthcare-Associated Pneumonia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Okayama University.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Streptococcus pneumoniae remains a common cause of community-acquired pneumonia but is an infrequent pathogen in hospital-acquired pneumonia (HAP). Non-vaccine serotypes of multidrug-resistant (MDR) S. pneumoniae strains have been emerging globally, posing an increased risk of nosocomial infection. Case A 71 year-old man developed pneumonia on postoperative day 4 following spinal fusion surgery. Despite initial treatment with ampicillin/sulbactam, his condition deteriorated, requiring ICU admission and mechanical ventilation. Microbiological testing confirmed S. pneumoniae as a causative pathogen, and ceftriaxone was empirically administered based on the local antibiogram. However, antimicrobial susceptibility testing revealed resistant profiles to penicillin (minimum inhibitory concentration [MIC], 8 µg/mL), ceftriaxone (MIC, 16 µg/mL), meropenem (MIC, 1 µg/mL), macrolides, and clindamycin, while demonstrating susceptibility to levofloxacin and vancomycin. The therapeutic regimen was subsequently adjusted to levofloxacin, resulting in clinical improvement. The isolate was later identified as serotype 15A, sequence type 63 (ST63).
Conclusion
This case highlights that MDR S. pneumoniae can cause early-onset HAP and may not be covered by standard empiric therapies, emphasizing the need for careful evaluation of treatment response. Continued surveillance of infections caused by vaccine-escape clones like MDR serotype 15A is essential, given their increasing clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
- Department of Bacteriology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.
- Department of General Medicine, Okayama University Hospital, Okayama, Japan.
- Department of Bacteriology I, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Infectious Diseases, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan. hagiya@okayama-u.ac.jp.
Förderung
- Okayama University
Zitieren
APA
Akazawa, H., Fukushima, S., Nakamoto, K., Oguni, K., Shimbe, M., Chang, B., Akeda, Y., & Hagiya, H. (2026). Hospital-acquired pneumonia caused by multidrug-resistant Streptococcus pneumoniae serotype 15A. Infection. https://doi.org/10.1007/s15010-025-02652-3
Vancouver
Akazawa H, Fukushima S, Nakamoto K, Oguni K, Shimbe M, Chang B, et al. Hospital-acquired pneumonia caused by multidrug-resistant Streptococcus pneumoniae serotype 15A. Infection. 2026. doi:10.1007/s15010-025-02652-3
BibTeX
@article{Akazawa2026,
author = {Akazawa, Hidemasa and Fukushima, Shinnosuke and Nakamoto, Kenta and Oguni, Kohei and Shimbe, Madoka and Chang, Bin and Akeda, Yukihiro and Hagiya, Hideharu},
title = {Hospital-acquired pneumonia caused by multidrug-resistant Streptococcus pneumoniae serotype 15A},
journal = {Infection},
year = {2026},
doi = {10.1007/s15010-025-02652-3}
}
EUVIMED